RxPrism Health System Pvt Ltd v Canva Pty Ltd

Link copied
Case Copied 19 min read

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

RxPrism Health System Pvt Ltd v Canva Pty Ltd [2023] APO 23

Patent Application:                2020202729

Title:Systems and methods of generating a website

Patent Applicant:                   Canva Pty Ltd

Opponent:  RxPrism Health System Pvt Ltd

Delegate:  Leslie F. McCaffery

Decision Date:  1 May 2023

Hearing Date:  9 March 2023 by videoconference and written submissions.

Catchwords:  PATENTS – section 223 – opposition to the grant of an extension of time to rely on the grace period prescribed in regulation 2.2C(3) –whether the failure to file within the grace period was an inevitable consequence of the deliberate use of an inadequate system – relevance of previous request for an extension on another application – full and frank disclosure – opposition unsuccessful – costs awarded.

Representation:  Counsel for the applicant: Cynthia Cochrane SC

Patent attorney for the applicant: FPA Patent Attorneys Pty Ltd

Patent attorney for the opponent: IP Guardian

IP AUSTRALIA

AUSTRALIAN PATENT OFFICE

Patent Application:                2020202729

Title:Systems and methods of generating a website

Patent Applicant:                   Canva Pty Ltd

Date of Decision:                   1 May 2023

DECISION

The opposition is unsuccessful.

I grant the extension of time of 12 months to file a complete application within the period set out by regulation 2.2C(3).

Costs according to Schedule 8 against the Opponent, RxPrism Health System Pvt Ltd.

REASONS FOR DECISION

  1. The present matter is an opposition to the grant of an extension of time under section 223(2)(a) to file a complete application within the grace period prescribed under section 24(1) and regulation 2.2C(3).  The original request was the subject of a decision by a Delegate of the Commissioner in Canva Pty Ltd [2021] APO 35 (Canva).  In short, the Delegate, taking all the relevant considerations into account, considered it appropriate to exercise the discretion in the favour of Canva Pty Ltd (the Applicant).  They directed that the application for an extension be advertised for opposition purposes.  This occurred on 30 September 2021.

  2. A Notice of Opposition was filed by RxPrism Health System Pvt Ltd (the Opponent) on 19 November 2021.  A Statement of Grounds and Particulars was filed on 1 December 2021, setting out grounds under sections 223(2)(a), 223(2)(b), 223(2A)(a) and 223(2A)(b).  The grounds of opposition under sections 223(2)(b), 223(2A)(a) and 223(2A)(b) were dismissed following a request by the Applicant, but an oppositions delegate considered that a prima facie case had been set out by the Opponent in relation to the ground of opposition under section 223(2)(a).

  3. Both parties filed evidence in the opposition.  Evidence in Support (EIS) consisted of a declaration by Dr Maruthi Viswanathan (Viswanathan 1), together with Annexures I to VII.  Evidence in Answer (EIA) consisted of a declaration by Mr Kirk Simmons (Simmons 2), together with Annexure B.[1]  Evidence in Reply (EIR) consisted of a second declaration by Dr Viswanathan (Viswanathan 2) together with Annexures VIII to XI.

    [1] Mr Simmons had previously filed a declaration in support of the request for an extension.  Annex…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read RxPrism Health System Pvt Ltd v Canva Pty Ltd and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2023] APO 23
Decision Date

CaseChat Overview and Summary

RxPrism Health System Private Limited contested Canva Pty Limited's application for an extension of time to rely on the grace period for a patent application. The dispute centred on whether the delay in filing was an inevitable result of RxPrism's deliberate use of an inadequate system. RxPrism argued that Canva's failure to file within the grace period was due to a deliberate decision to use an inadequate system, which led to the delay. The opposition also questioned whether previous requests for an extension on another application were relevant and whether Canva had made a full and frank disclosure to the relevant authorities. The court had to determine the validity of these arguments and decide if the application for an extension should be granted.

The primary legal issues before the court were whether the delay in filing was an inevitable consequence of RxPrism's inadequate system and whether the previous requests for an extension on another application were pertinent to the current dispute. Additionally, the court had to consider whether Canva had made a full and frank disclosure to the relevant authorities, as this would impact the credibility of their application for an extension. The court needed to assess the evidence presented by both parties and determine if the application for an extension should be granted or opposed.

The court found that RxPrism had not demonstrated that the delay in filing was an inevitable consequence of their inadequate system. The court also ruled that the previous requests for an extension on another application were not relevant to the current dispute. Furthermore, the court held that Canva had made a full and frank disclosure to the relevant authorities, which supported their application for an extension. Consequently, the opposition was unsuccessful, and the application for an extension was granted. The court awarded costs to Canva, acknowledging their successful opposition to RxPrism's application.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

Full text does not contain this section.

Evidence

Evidence Before The Court

Full text does not contain this section.

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.